Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first patients in the US have been successfully treated ...
Zacks Investment Research on MSN
Stereotaxis stock up on first US MAGIC procedures post approval
Stereotaxis STXS has announced the first successful U.S. procedures using its MAGiC robotic magnetic ablation catheter, ...
Stereotaxis has completed the first U.S. procedures using its FDA‑approved MAGiC robotic magnetic ablation catheter, designed for complex congenital heart disease cases where traditional approaches ...
Biosense Webster’s Thermocool SmartTouch SF dual-energy catheter enables the use of both radio-frequency (RF) and pulse-field (PF) techniques in catheter ablation procedures. The SmartfIRE pivotal, ...
Stereotaxis (NYSE:STXS) today announced the first patients successfully treated in the U.S. with its MAGiC system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results